-
Innovation Ranking
NewInnovation Ranking – WIN Semiconductors Corp
WIN Semiconductors Corp (WIN) is a manufacturer and distributor of semiconductor products. The company provides gallium arsenide (GaAs) microwave integrated circuits (MMICs) and radio frequency integrated circuits (RFICs). It supplies Heterojunction Bipolar Transistor (HBT) and Strained Heterojunction High Mobility Transistor (pHEMT) services to IC manufacturers. The company offers optoelectronic component technology providing services such as epiwafer growth, optoelectronic component manufacturing such as laser diodes and photodetector diodes, and related testing among others. WIN's optical communication and optical information components include...
-
Analyst Opinions
Opportunities for Winning Consumers Beyond Sportspeople Through High-Protein Snacking Innovations
Opportunities for Winning Consumers Beyond Sportspeople Through High-Protein Snacking Innovations Overview The rising health consciousness, dietary trends, product innovations, and recognition of protein's importance in maintaining a balanced diet and active lifestyle are making protein intake popular. Furthermore, positive perceptions about protein's ability to help consumers lose weight, gain physical strength, and avoid age-related muscle loss have resulted in the rise of low-carb diets such as Paleo, Atkins, and the Zone, which elevate the importance of protein consumption. On the...
-
Company Insights
Innovation and Patenting activity of WIN Semiconductors Corp Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of WIN Semiconductors Corp Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Company Insights
Innovation and Patenting activity of Winning Health Technology Group Co Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Winning Health Technology Group Co Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The...
-
Analyst Opinions
Top Trends in Packaging – Industry Insights
Top Trends in Packaging Industry Report Overview The packaging industry is adopting various cost-saving measures to enhance efficiency and maintain competitiveness. They are also enhancing their logistics and automation processes to optimize operations and reduce costs. Furthermore, the industry is focusing on sustainability to meet the demand for eco-friendly packaging solutions. By capitalizing on these trends and enhancing efficiency, companies are better placed to navigate challenges such as falling consumer spending and rising energy, material, and labor input costs. The...
-
Analyst Opinions
HNW Asset Allocation Trends, Investment Drivers and Preferences, 2024 Update
Reasons to buy the ‘HNW Asset Allocation Trends’ report: Get an overview of the key themes for investment in 2024, including inflation, interest rates, geopolitical risk, and war​. Gain insight into the retail and HNW investment portfolios and what this means for 2024 allocations. Access a detailed review of the reliance on asset managers in the investment portfolio and the drivers motivating HNW investors in each asset category. Analyze HNW asset allocation strategies in 24 key markets and examine the drivers behind investment...
-
Sector Analysis
Czech Republic Defense Market Size, Trends, Budget Allocation, Regulations, Acquisitions, Competitive Landscape and Forecast to 2028
Czech Republic Defense Market Report Overview As of 2023, the Czech Republic defense budget was worth $4.7 billion. The country’s defense budget is set to see high levels of growth, registering a CAGR of more than 9% between 2024 and 2028. Factors such as the significant changes in the defense and security posture of the Czech Republic as a result of Russia’s 2022 full-scale invasion of Ukraine and expansion of military capability are driving the Czech Republic's defense market growth....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (IO-102 + IO-103) in Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (IO-102 + IO-103) in Melanoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (IO-102 + IO-103) in Melanoma Drug Details: PD-L1/IDO (IO102/IO103) peptide vaccine...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (IO-102 + IO-103) in Hypopharyngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (IO-102 + IO-103) in Hypopharyngeal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (IO-102 + IO-103) in Hypopharyngeal Cancer Drug Details: PD-L1/IDO (IO102/IO103)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (IO-102 + IO-103) in Laryngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (IO-102 + IO-103) in Laryngeal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (IO-102 + IO-103) in Laryngeal Cancer Drug Details: PD-L1/IDO (IO102/IO103)...